Clinical burden and health service challenges of chronic heart failure.
作者信息
Richard Hobbs F D
机构信息
Head of School of Health and Population Sciences, professor and head of primary care, Department of Primary Care Clinical Sciences, University of Birmingham.
出版信息
Br J Gen Pract. 2010 Aug;60(577):611-5. doi: 10.3399/bjgp10X515133.
Abstract
摘要
相似文献
1
Clinical burden and health service challenges of chronic heart failure.
Br J Gen Pract. 2010 Aug;60(577):611-5. doi: 10.3399/bjgp10X515133.
2
Improving patient outcomes in heart failure: evidence and barriers.
Heart. 2000 Sep;84 Suppl 1(Suppl 1):i8-10:discussion i50. doi: 10.1136/heart.84.suppl_1.i8.
3
Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Pharmacotherapy. 2016 Feb;36(2):174-86. doi: 10.1002/phar.1701. Epub 2016 Feb 3.
4
Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?
Nat Clin Pract Cardiovasc Med. 2004 Nov;1(1):10-1. doi: 10.1038/ncpcardio0005.
5
Treating patients with Chagas' cardiomyopathy with chronic heart failure in the contemporary era.
Am Heart J. 2007 Nov;154(5):e35; author reply e33. doi: 10.1016/j.ahj.2007.07.052. Epub 2007 Sep 27.
6
Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
J Am Coll Cardiol. 2004 Apr 7;43(7):1333; author reply 1333-4. doi: 10.1016/j.jacc.2004.01.005.
7
Suggestions to improve the quality of life in heart failure.
Eur Heart J. 2003 Sep;24(18):1700. doi: 10.1016/s0195-668x(03)00432-9.
8
[Progress in therapy of heart failure. Mortality halved].
MMW Fortschr Med. 2003 Apr 17;145(16):4-5.
9
[Non-drug treatment of chronic cardiac insufficiency: exercise and rhythm control prolong the patient's life].
MMW Fortschr Med. 2005 Sep 1;147(35-36):25.
10
Left ventricular assist devices are underutilized.
Circulation. 2011 Apr 12;123(14):1552-8; discussion 1558. doi: 10.1161/CIRCULATIONAHA.110.958991.
引用本文的文献
1
Missed opportunities in heart failure diagnosis and management: study of an urban UK population.
ESC Heart Fail. 2024 Aug;11(4):2200-2213. doi: 10.1002/ehf2.14766. Epub 2024 Apr 16.
2
Resource utilisation and outcomes of people with heart failure in England: a descriptive analysis of linked primary and secondary care data - the PULSE study.
Open Heart. 2023 Dec 9;10(2):e002467. doi: 10.1136/openhrt-2023-002467.
3
Incidence and prevalence of heart failure in England: a descriptive analysis of linked primary and secondary care data - the PULSE study.
BMC Cardiovasc Disord. 2023 Jul 26;23(1):374. doi: 10.1186/s12872-023-03337-1.
4
The Application of Porous Scaffolds for Cardiovascular Tissues.
Bioengineering (Basel). 2023 Feb 10;10(2):236. doi: 10.3390/bioengineering10020236.
5
Economic Burden of Heart Failure in Asian Countries with Different Healthcare Systems.
Korean Circ J. 2021 Aug;51(8):681-693. doi: 10.4070/kcj.2021.0029. Epub 2021 May 21.
6
Healthcare professionals' perception of quality of care of patients with cardiac disease in Nigeria: Implication for clinical guideline, inter-professional education and team work.
Malawi Med J. 2019 Mar;31(1):31-38. doi: 10.4314/mmj.v31i1.6.
7
Injectable Hydrogels for Cardiac Tissue Engineering.
Macromol Biosci. 2018 Jun;18(6):e1800079. doi: 10.1002/mabi.201800079. Epub 2018 May 7.
8
Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece.
Clinicoecon Outcomes Res. 2016 Oct 12;8:583-590. doi: 10.2147/CEOR.S107831. eCollection 2016.
9
Family and friend participation in primary care visits of patients with diabetes or heart failure: patient and physician determinants and experiences.
Med Care. 2011 Jan;49(1):37-45. doi: 10.1097/MLR.0b013e3181f37d28.
本文引用的文献
1
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).
Eur Heart J. 2008 Oct;29(19):2388-442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17.
2
Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES).
Eur Heart J. 2007 May;28(9):1128-34. doi: 10.1093/eurheartj/ehm102. Epub 2007 Apr 25.
3
Trends in prevalence and outcome of heart failure with preserved ejection fraction.
N Engl J Med. 2006 Jul 20;355(3):251-9. doi: 10.1056/NEJMoa052256.
4
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.
Circulation. 2005 Sep 20;112(12):e154-235. doi: 10.1161/CIRCULATIONAHA.105.167586. Epub 2005 Sep 13.
5
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
J Am Coll Cardiol. 2005 Aug 2;46(3):425-31. doi: 10.1016/j.jacc.2005.04.038.
6
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
N Engl J Med. 2004 Aug 5;351(6):543-51. doi: 10.1056/NEJMoa040135.
7
Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations.
Heart. 2004 Aug;90(8):866-70. doi: 10.1136/hrt.2003.014258.
8
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
Lancet. 2003 Sep 6;362(9386):759-66. doi: 10.1016/s0140-6736(03)14282-1.
9
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.
Eur Heart J. 2003 Mar;24(5):442-63. doi: 10.1016/s0195-668x(02)00823-0.
10
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.
Lancet. 2002 Nov 23;360(9346):1631-9. doi: 10.1016/s0140-6736(02)11601-1.
Zotero 插件